Colorectal liver metastases growth in the embolized and non-embolized liver after portal vein embolization: Influence of initial response to induction chemotherapy

Annals of Surgical Oncology

Volumn 21, Issue 9, 2014, Pages 3077-3083

  Pommier, Romain ^a   Ronot, Maxime ^a,b,c   Cauchy, François ^b,d   Gaujoux, Sébastien ^b,d   Fuks, David ^b,d   Faivre, Sandrine ^a,b   Belghiti, Jacques ^b,d   Vilgrain, Valérie ^a,b,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^d BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; LIVER PARENCHYMA; LIVER PORTAL VEIN EMBOLIZATION; LIVER RESECTION; LIVER WEIGHT; MALE; RISK FACTOR; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VOLUME; WEDGE RESECTION; CANCER STAGING; COLORECTAL NEOPLASMS; FOLLOW UP; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PORTAL VEIN; PROGNOSIS; SECONDARY; SURVIVAL RATE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDUCTION CHEMOTHERAPY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PORTAL VEIN; PROGNOSIS; SURVIVAL RATE;

EID: 84906216774     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3700-z     Document Type: Article

References (33)

1. Folprecht G, Gruenberger T, Bechstein WO, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol. 2010;11:38-47.
2. Farges O, Belghiti J, Kianmanesh R, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg. 2003;237:208-17. (Pubitemid 38173248)
3. Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247:49-57.
4. Alberts SR. Update on the optimal management of patients with colorectal liver metastases. Crit Rev Oncol Hematol. 2012;84:59-70.
5. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg. 2001;88:165-75. (Pubitemid 32142701)
6. Dinant S, de Graaf W, Verwer BJ, et al. Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med . 2007;48:685-92. (Pubitemid 47604966)
7. de Baere T, Teriitehau C, Deschamps F, et al. Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol. 2010;17:2081-089.
8. Pamecha V, Glantzounis G, Davies N, Fusai G, Sharma D, Davidson B. Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases. Ann Surg Oncol. 2009;16:1202-7.
9. Pamecha V, Nedjat-Shokouhi B, Gurusamy K, Glantzounis GK, Sharma D, Davidson BR. Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolisation and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases. Dig Surg. 2008;25:387-93.
10. Jamdar S, Jegatheeswaran S, Bandara A, Sheen AJ, Siriwardena AK. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg. 2010;97:240-50.
11. Fuks D, Cook MC, Brehant O, et al. Colorectal carcinoma with potentially resectable metastases: factors associated with the failure of curative schedule. Gastroenterol Clin Biol. 2008;32:390-400.
12. Lim C, Cauchy F, Azoulay D, Farges O, Ronot M, Pocard M. Tumour progression and liver regeneration-insights from animal models. Nat Rev Gastroenterol Hepatol. 2013;10:452-62.
13. van Gulik TM, van den Esschert JW, de Graaf W, et al. Controversies in the use of portal vein embolization. Dig Surg. 2008;25:436-44.
14. de Graaf W, van den Esschert JW, van Lienden KP, van Gulik TM. Induction of tumor growth after preoperative portal vein embolization: is it a real problem? Ann Surg Oncol. 2009;16:423-30.
15. Elias D, De Baere T, Roche A, Mducreux, Leclere J, Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg. 1999;86:784-8. (Pubitemid 29271944)
16. Kokudo N, Tada K, Seki M, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology. 2001;34:267-72. (Pubitemid 32702339)
17. Barbaro B, Di Stasi C, Nuzzo G, Vellone M, Giuliante F, Marano P. Preoperative right portal vein embolization in patients with metastatic liver disease. Metastatic liver volumes after RPVE. Acta Radiol. 2003;44:98-102.
18. Hayashi S, Baba Y, Ueno K, et al. Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization. Acta Radiol. 2007;48:721-7. (Pubitemid 47338637)
19. Pamecha V, Levene A, Grillo F, Woodward N, Dhillon A, Davidson BR. Effect of portal vein embolisation on the growth rate of colorectal liver metastases. Br J Cancer. 2009;100:617-22.
20. Maggiori L, Bretagnol F, Sibert A, Paradis V, Vilgrain V, Panis Y. Selective portal vein ligation and embolization induce different tumoral responses in the rat liver. Surgery. 2011;149:496-503.
21. Bretagnol F, Maggiori L, Zappa M, Sibert A, Vilgrain V, Panis Y. Selective portal vein embolization and colorectal liver metastases in rat: a new experimental model for tumor growth study. J Surg Res. 2011;171:669-74.
22. Cauchy F, Aussilhou B, Dokmak S, et al. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases. Ann Surg. 2012;256:746-52.
23. Fischer C, Melstrom LG, Arnaoutakis D, et al. Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy. JAMA Surg. 2013;148:1103-8.
24. Capussotti L, Muratore A, Baracchi F, et al. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases. Arch Surg. 2008;143:978-82.
25. de Baere T, Denys A, Madoff DC. Preoperative portal vein embolization: indications and technical considerations. Tech Vasc Interv Radiol. 2007;10:67-78. (Pubitemid 350008082)
26. Tanaka K, Kumamoto T, Matsuyama R, Takeda K, Nagano Y, Endo I. Influence of chemotherapy on liver regeneration induced by portal vein embolization or first hepatectomy of a staged procedure for colorectal liver metastases. J Gastrointest Surg. 2010;14:359-68.
27. Hoekstra LT, van Lienden KP, Doets A, Busch OR, Gouma DJ, van Gulik TM. Tumor progression after preoperative portal vein embolization. Ann Surg. 2012;256:812-8.
28. Denys AL, Abehsera M, Leloutre B, et al. Intrahepatic hemodynamic changes following portal vein embolization: a prospective Doppler study. Eur Radiol. 2000;10:1703-7.
29. Archer SG, Gray BN. Vascularization of small liver metastases. Br J Surg . 1989;76:545-8. (Pubitemid 19155723)
30. Christophi C, Harun N, Fifis T. Liver regeneration and tumor stimulation: a review of cytokine and angiogenic factors. J Gastrointest Surg. 2008;12:966-80.
31. Paschos KA, Bird NC. Liver regeneration and its impact on posthepatectomy metastatic tumour recurrence. Anticancer Res. 2010;30:2161-70.
32. Elias D, Santoro R, Ouellet JF, Osmak L, de Baere T, Roche A. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases. Hepatogastroenterology. 2004;51:1788-91.
33. de Santibanes E, Clavien PA. Playing play-doh to prevent postoperative liver failure: the "ALPPS" approach. Ann Surg. 2012;255:415-7.